PHOENIX--(BUSINESS WIRE)--Apr 17, 2026--

Geviti Health, a precision health platform focused on preventative care, has announced the launch of an AI-powered health intelligence system that delivers clinically validated insights into blood biomarkers at no cost.

The platform introduces what Geviti describes as a first-to-market free offering, using AI to accelerate multi-system health analysis while supporting clinical decision-making within a human-led care model. It addresses a growing gap in preventative healthcare, where cost and complexity continue to limit access to comprehensive testing and interpretation.

Geviti aggregates data from advanced diagnostics to identify patterns and surface actionable insights, enabling faster and more comprehensive analysis at scale.

Unlike traditional models that rely on static lab interpretation or generalized recommendations, Geviti combines AI-driven analysis with expert oversight to deliver individualized health blueprints alongside ongoing monitoring and guided patient support.

“AI should not replace the human element in healthcare, it should enhance it,” said Nate Graville, founder of Geviti. “We use AI as a force multiplier, allowing our team to analyze significantly more data across biomarkers, genetics, and medical history with greater precision and speed, while still delivering personalized, human-led care.”

Graville emphasized that the platform prioritizes outcomes and patient-specific insights over generalized recommendations. “It’s not about generating more data. It’s about interpreting it correctly and turning it into meaningful action,” he said.

The launch comes amid increased adoption of AI in healthcare. While many companies are pursuing fully automated models, Geviti positions its approach as hybrid—using AI to scale capabilities while keeping clinicians central to the process.

The feature is now available on the Geviti app and website through its free tier.

About Geviti

Geviti is a precision health platform focused on preventative care through advanced diagnostics, personalized protocols, and ongoing health optimization. The company integrates blood testing, genetic analysis, and additional diagnostic tools to deliver individualized health insights and recommendations.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260417888303/en/

CONTACT: Media Contact:

Melanie DeFilippis

Coda Public Relations on behalf of Geviti

melanie@codapr.com

2602413395

KEYWORD: ARIZONA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: TECHNOLOGY HEALTH TECHNOLOGY TELEMEDICINE/VIRTUAL MEDICINE SOFTWARE BIOTECHNOLOGY HEALTH GENERAL HEALTH DATA MANAGEMENT ARTIFICIAL INTELLIGENCE

SOURCE: Geviti Health

Copyright Business Wire 2026.

PUB: 04/17/2026 05:00 AM/DISC: 04/17/2026 05:02 AM

http://www.businesswire.com/news/home/20260417888303/en